Tag Archives: TB Treatment

‘Future looks promising for MDR-TB patients’

Dr Srinivas Rao Ghattamaneni is a senior MSF MDR-TB/HIV doctor who recently returned from Ukraine after serving there as a tuberculosis (TB) specialist.

Posted in INTERVIEWS | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Management of drug-resistant TB: Q&A for primary care physicians

This article, one of the chapters of a new TB book called ‘Let’s Talk TB’ aimed at GPs in India (published by GP Clinics, available free at www.letstalktb.org) covers commonly asked questions by the primary care doctor about identification and referral of patients with suspected or confirmed DR-TB.

Posted in OPINIONS | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Management of Tuberculosis: 10 Common Pitfalls to Avoid

Even if the diagnostic hurdle is overcome, TB treatment in the private sector is far from standard. When private practitioners initiate anti-TB treatment (ATT), they tend to use drug regimens that are not recommended by WHO or the Standards of TB Care in India (STCI).

Posted in BOOKS | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Daily antibiotics may prevent drug-resistant TB

New York: Prescribing antibiotic doses once or twice a week for tuberculosis (TB) treatment are more likely to lead to drug resistant strains than daily antibiotic regimens, new research has found.

Posted in Medicine, RESEARCH | Tagged , , , , , , | Leave a comment

Adding blood pressure drug to standard antibiotics speeds up TB treatment

Washington: Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.

Posted in Medicine, RESEARCH | Tagged , , , , , | Leave a comment